コンテンツへスキップ
Merck
  • Nf2-Yap signaling controls the expansion of DRG progenitors and glia during DRG development.

Nf2-Yap signaling controls the expansion of DRG progenitors and glia during DRG development.

Developmental biology (2014-11-30)
Yelda Serinagaoglu, Joshua Paré, Marco Giovannini, Xinwei Cao
要旨

Molecular mechanisms governing the maintenance and proliferation of dorsal root ganglia (DRG) progenitors are largely unknown. Here we reveal that the Hippo pathway regulates the expansion of DRG progenitors and glia during mammalian DRG development. The key effectors of this pathway, transcriptional coactivators Yap and Taz, are expressed in DRG progenitors and glia during DRG development but are at least partially inhibited from activating transcription. Aberrant YAP activation leads to overexpansion of DRG progenitor and glial populations. We further show that the Neurofibromatosis 2 (Nf2) tumor suppressor inhibits Yap during DRG development. Loss of Nf2 leads to similar phenotypes as does YAP hyperactivation, and deleting Yap suppresses these phenotypes. Our study demonstrates that Nf2-Yap signaling plays important roles in controlling the expansion of DRG progenitors and glia during DRG development.

材料
製品番号
ブランド
製品内容

Sigma-Aldrich
抗GAPDH抗体、マウスモノクローナル, clone GAPDH-71.1, purified from hybridoma cell culture
Sigma-Aldrich
モノクロナール抗S-100 (β-サブユニット) マウス宿主抗体, clone SH-B1, ascites fluid
Sigma-Aldrich
抗脳脂質結合タンパク質抗体, from rabbit, purified by affinity chromatography
Sigma-Aldrich
抗NF2 ウサギ宿主抗体, Prestige Antibodies® Powered by Atlas Antibodies, affinity isolated antibody, buffered aqueous glycerol solution